自动化虚拟现实疗法治疗精神病患者广场恐惧回避与痛苦:gameChange 多中心随机对照试验
gameChange 是一项在英格兰九家 NHS 信托开展的多中心、平行组、单盲随机对照试验,纳入 346 例有外出焦虑困难的精神病患者,比较自动化 VR 认知疗法联合常规照护与单纯常规照护。6 周时,VR 组在 O-AS 回避与痛苦上均较常规照护组显著降低,威胁认知与情境内防御行为起中介作用,焦虑恐惧与回避越严重者获益越大。
核心结论
- 与单纯常规照护相比,自动化 VR 疗法使精神病患者日常情境的焦虑回避与痛苦显著降低。
- 中介分析表明 VR 疗法通过减少焦虑想法与相关保护行为起效,符合认知模型。
- 调节分析表明 VR 疗法尤其使严重广场恐惧回避(如无法独自离家)患者获益。
研究设计与样本
- 平行组、单盲、随机对照试验,在英格兰九家 NHS 信托开展,随机分配比例 1:1。
- 纳入 346 例 16 岁以上、临床诊断为精神分裂症谱系障碍或伴精神病性症状的情感障碍且自报因焦虑外出困难的患者。
- gameChange VR 疗法约 6 次会话、为期 6 周,联合常规照护,对照为单纯常规照护;主要终点为 6 周。
- 主要结局为自报牛津广场恐惧回避量表(O-AS)评估的日常情境回避与痛苦,在意向性治疗人群分析。
主要发现
- 威胁认知与情境内防御行为的减少中介了治疗结局。
- 焦虑恐惧与回避越严重,治疗获益越大。
临床怎么用
- 自动化 VR 认知疗法可作为常规照护的辅助,用于有外出焦虑回避的精神病患者。
- 对严重广场恐惧回避(如无法独自离家)的患者,VR 疗法可能尤其获益。
- 该疗法有潜力增加精神病患者获得有效心理治疗的机会,尤其对难以离家、前往本地设施或使用公共交通者。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Automated delivery of psychological therapy using immersive technologies such as virtual reality (VR) might greatly increase the availability of effective help for patients. We aimed to evaluate the efficacy of an automated VR cognitive therapy (gameChange) to treat avoidance and distress in patients with psychosis, and to analyse how and in whom it might work. METHODS: We did a parallel-group, single-blind, randomised, controlled trial across nine National Health Service trusts in England. Eligible patients were aged 16 years or older, with a clinical diagnosis of a schizophrenia spectrum disorder or an affective diagnosis with psychotic symptoms, and had self-reported difficulties going outside due to anxiety. Patients were randomly assigned (1:1) to either gameChange VR therapy plus usual care or usual care alone, using a permuted blocks algorithm with randomly varying block size, stratified by study site and service type. gameChange VR therapy was provided in approximately six sessions over 6 weeks. Trial assessors were masked to group allocation. Outcomes were assessed at 0, 6 (primary endpoint), and 26 weeks after randomisation. The primary outcome was avoidance of, and distress in, everyday situations, assessed using the self-reported Oxford Agoraphobic Avoidance Scale (O-AS). Outcome analyses were done in the intention-to-treat population (ie, all participants who were assigned to a study group for whom data were available). We performed planned mediation and moderation analyses to test the effects of gameChange VR therapy when added to usual care. This trial is registered with the ISRCTN registry, 17308399. FINDINGS: Between July 25, 2019, and May 7, 2021 (with a pause in recruitment from March 16, 2020, to Sept 14, 2020, due to COVID-19 pandemic restrictions), 551 patients were assessed for eligibility and 346 were enrolled. 231 (67%) patients were men and 111 (32%) were women, 294 (85%) were White, and the mean age was 37·2 years (SD 12·5). 174 patients were randomly assigned to the gameChange VR therapy group and 172 to the usual care alone group. Compared with the usual care alone group, the gameChange VR therapy group had significant reductions in agoraphobic avoidance (O-AS adjusted mean difference -0·47, 95% CI -0·88 to -0·06; n=320; Cohen's d -0·18; p=0·026) and distress (-4·33, -7·78 to -0·87; n=322; -0·26; p=0·014) at 6 weeks. Reductions in threat cognitions and within-situation defence behaviours mediated treatment outcomes. The greater the severity of anxious fears and avoidance, the greater the treatment benefits. There was no significant difference in the occurrence of serious adverse events between the gameChange VR therapy group (12 events in nine patients) and the usual care alone group (eight events in seven patients; p=0·37). INTERPRETATION: Automated VR therapy led to significant reductions in anxious avoidance of, and distress in, everyday situations compared with usual care alone. The mediation analysis indicated that the VR therapy worked in accordance with the cognitive model by reducing anxious thoughts and associated protective behaviours. The moderation analysis indicated that the VR therapy particularly benefited patients with severe agoraphobic avoidance, such as not being able to leave the home unaccompanied. gameChange VR therapy has the potential to increase the provision of effective psychological therapy for psychosis, particularly for patients who find it difficult to leave their home, visit local amenities, or use public transport. FUNDING: National Institute of Health Research Invention for Innovation programme, National Institute of Health Research Oxford Health Biomedical Research Centre.
引用
- Freeman D, Lambe S, Kabir T, et al. Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses. Lancet Psychiatry. 2022. PMID: 35395204. doi:10.1016/S2215-0366(22)00060-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。